Viewing nowCombinationDualstar Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.

MFDS item code 201704544 · Approved 2017.06.21 · Insurance code 643704440
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with either amlodipine or telmisartan monotherapy. It is effective in helping to stabilize and manage blood pressure when control is insufficient.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of each individual component (telmisartan or amlodipine) be adjusted before starting this medicine. However, switching directly to this medicine may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). · Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. · Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. This drug should not be used by individuals with specific diseases, those who are pregnant or breastfeeding, patients with severely impaired liver or heart function, or those with hypotension. Particular caution is necessary when this medication is used by patients with primary aldosteronism, heart valve disease, liver impairment, gastrointestinal disorders, kidney diseases, and the elderly. Common side effects of this medication may include dizziness and swelling of the arms or legs, although serious side effects can occur rarely; consult a doctor immediately if any abnormal symptoms appear. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued immediately and replaced with a safer treatment. This medication can interact with other drugs, so if you are taking any other medications, be sure to inform your healthcare provider, especially if using drugs that affect potassium levels, as potassium levels should be monitored regularly through blood tests. This drug may cause drowsiness or dizziness when driving or operating machinery, so caution is advised. In case of overdose, symptoms such as hypotension, dizziness, or heart irregularities may appear, and immediate medical assistance should be sought, along with proper emergency treatment. This medication is not recommended for children, and for the elderly, starting with a lower dose and gradually increasing the dosage is preferable. Store this medication out of the reach of children, keeping it dry and protected from moisture, and take it immediately after opening the packaging.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a tightly closed container that protects it from light. Additionally, it is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and safety.
A biconvex oval double tablet that is white and light gray.
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.